SUMMARY The use of cerebral electrotherapy (CET) in methadone detoxifica tion was studied in 28 patients. Fourteen patients received active CET; the other 14 acted as controls and received either simulated CET or only methadone detoxification therapy. One patient dropped out of the study. The Taylor Manifest Anxiety Scale and the Hamilton Anxiet y Scale were administered before and after the stud y period. Nine of the patients receiving active CET were drug free by the end of 8 to 10 days, and aJl experienced a marked reduction of their symptoms; the control group did not show significant changes. CET was clearly beneficial in the treatment of patients undergoing methadone withdrawal.
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We undertook a research project in order to develop a technique for dealing with heroin addicti on a nd methadone withdrawal. In the present stud y, we report on th e effect o f cerebral electrotherapy (CET ), in patients at the Drug Addiction Unit at th e Veterans Administrati on West Side Ho spital, which is a fl ilia tcd with the University o f Illinois in Chicago.
CET was introduced into use in the United States b y S. Rosenth al and co-workers ( 19 70, 1972a, band c) at the University o f Texas Medical School at San Antonio, T exas . The technique had be en used exte nsive ly in Rus sia for many years . It was given primarily to patients suffering fr om chronic anxiety, insomnia o r mild depression. Recently oth er workers have be en using it with pati ents during their withdrawal from a lco h o l (e.g . H ood , 1972), Nothing h as appeared in th e lit erature on the use o f CET in heroin o r m e tha d o ne withdrawal.
Method
The o b jec tives of th e study wer e to determine ( 1) wh ether a nxiety de cre as es clinicall y, as measured with a n xie ty rating scal es, a fter CET ; (2) wh eth er th e amount o f methadone intake de creases graduall y with th e use o f C ET; a nd (3) wh ether CET improves (bo th clini cally and subjectively) th e patient 's sleep.
The cr iteri a for patient selecti on were: (1 ) h er oin addiction a nd enrolment th e m ethadone maintenance programme, I.e. admis sion to th e hospital for voluntary de toxifi cati on (withdrawal ); (2) th e presen ce of anxiety as measured by the Hamilton Anxiety Sca le (H AS) and by th e sel l-ad m in iste re d Taylor Anxi e ty Scal e (T MAS) test (Fa r be r and Spence, 1955) in which the pati ent scored at least out of a maximum 50 sta teme n ts a nxiety; (3) di Hi cuities in sleeping ; (4) willingness to parti cip ate in th e study tor a t least two weeks in a lock ed wa rd ; (5 ) n ot to tak e an y tra n q u illizer s o r hypn otic med icati ons while in th e study; (6) age d b etw een 18 a n d 60 years , Becau se 01 th e nature o l the h o spital, a ll th e su bjects were m ale .
28 pati ents were rando mly divi ded into two gr oups . The trea tme n t gro up wa s of 14 patients wh o initiall y had T MAS score s ranging from 23 to 48, a n intake m ethadone of fro m 20 to 60 m g p er da y, anx iety as in d ica ted by HAS sco re s, in so mnia , p sych osomati c compl aints , an d m ild depres sion, This grou p re cei ved CET with curre nt freq uency o f 100 pulses per seco nd a nd a pulse d ura tio n of 2 m s an d with no base line d irec t current bi as, Moist electrod es were ap p lied lC th e fo reh ead ab ove th e eyeb ro ws a nd on the ma stoi d processes. The curre n t was regulated so that the pati ent felt a sligh t, but not unco mfor table, tin glin g se nsa -
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University o f Illinois in Chicago. Spence , 1955) in which the pati ent scored at least CET was introduced into use the United 20 out of a maximum 50 sta temen ts l tion o ver his supraorbi tal-frontal region and / or mastoid pro ce sses . This was usuall y produced a curre n t readin g o f 0.4 to 1.3 MA . With a high er current the pa tient felt uncom fortabl e , b u t th ere were no skin b u rn s. A treatment la sted for 30 minutes, and each pati ent wa s treated ten times (o n ce a day, M onda y throu gh Frida y, for two w ee ks) A n a tte n da nt remain ed wi th the patient during the tr eatment , wh ic h g ive n in a d ar ke ned w he re th e p ati ent usually reclin ed o n a cou ch.
Th e control g ro u p was rand omly d ivid ed into sub gro u ps , A and B, eac h contain ing 7 pati ents.
Subgroup A p ati ents initially had T MAS sc ores ranging fr om 22 to 4 1 a nd an initi al intake o f m ethado ne 30 to 4 0 m g . Th e ir HAS scores indicated severe an xiety , in somni a , psych o somatic complaints and mil d d e p ress io n . Th e pati ents in Sub group A re ceiv ed inactive {sim u la ted} treatment. Simulated CET wa s a d m in iste re d b y applying the in th e usual wa y but with out connecting the lea ds to th e machine . The patient h eard the loud cli cking noise which usuall y indi cates that the machine is o n , but since it was not co n nec ted they did n ot any tingling sensation.
Su bgroup B patients initi ally had TMAS scores ranging from 2 8 to 40 a n d an initial intake of metha done o f fro m 25 to 40 m g. Th eir HAS sco re s sh owed severe anxiety, insomnia, somati c co m p la in ts, a n d mild depre ssi on. They did n ot either active or simul ated CET.
Results
Of the 14 patients who active CET, 7 had their anxi ety red uc ed normal levels , the mean TMAS for the group falling fr o m 3 1 treatment) to 20 {after 10 d ays }. (N o r m a l sco res in TM AS is in a range of from 8 to 18 .) The other 7 pat ients s howe d a 25 to 50 p er cent re d uct io n in TMAS scores a n xie ty. The metha done intake wa s redu ced considerabl y in a ll. At th e end 6 to 8 tr eatments with CET th e methadone intake for 9 o f th e patients was zero, a nd at the en d of 10 ses sion s a n ad ditional patient wa s not takin g methadone . Only thre e patients were raki ng methadone (I ro rn 10 to 15
at th e conclusion 10 tr eatments with CET. In this group, one patient dropped out study th e lirst treatment.
The su bjec t ive ex p eri e nc e o f th e pa tien ts wa s o f b ein g r e stful and of h aving a ge ne ra l o f well-be ing.
al so sta te d that th eir sleep g ood a nd u ndi stur b e d a fter the th ird tr eatm ent o f CET. Fo r th ese pa tients the sco res o f al l HAS ite ms diminished . For the p atien ts r ece iving s imu la te d CET, th e change s in TM A S sco re slight, the me an va lue fallin g fro m 29
27. T he m eth ad one intake d id n o t ch an ge in 4 p ati ents a Irer 10 trea t m ents; m eth a do ne re d u ct io n in th e 3 p ati ents was 5 to 10 mg. T hese 7 pa tients co m p la ined o f' n or sle ep ing had a nu m ber o f somatic com p la in ts, a nd b oth a n x io u s and d epres sed . Th e HA S score did not sho w m uch va ria t ion whe n co m pared with th e initial score . I n the present s tu d y th e m ajority of patients re cei vin g a cti ve C h.T d r ug -free th e end tre atments , and in t hose wh o were n ot dr ug-fre e , d r ug intake d ecreas ed by mo re 80 p er ce nt. Sym ptoms, a s cl in ica lly or objectively measured by th e rating sca le s, were m a rk edl y reduced. Alth ough some p atients went to sle ep during th e treatment re gardless o f the le vel o f cu r re nt , usuall y did not allec t th e outcom e . ..
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